AI-generated summary
The authors review how daily biological rhythms and mitochondrial function may interact, focusing on whether the timing of near-infrared photobiomodulation therapy could matter for age-related retinal disease. They report emerging evidence that the therapy may improve mitochondrial function and visual performance, but that its efficacy is time-dependent. The abstract states that further research is needed to identify optimal treatment times and individual responses.
- Who or what was studied
- unclear
- Limits stated in the abstract
- The abstract describes emerging evidence and calls for further research, without reporting specific study data, sample sizes or outcome measures.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Near-infrared. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.